Received Feb 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | 57H54 | — |
patient was administered with an expired dose of Menveo; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 57H54, expiry date 31-JAN-2026) for prophylaxis. On 03-FEB-2026, the patient received the 1st dose of Menveo .5 ml. On 03-FEB-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: patient was administered with an expired dose of Menveo). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 04-FEB-2026 The patient wanted to know how they should proceed. The batch number was provided upon follow up with the reporter.